News Focus
News Focus
icon url

Investor2014

11/20/25 8:03 AM

#509078 RE: Cpap21 #509076

The question now for those who still hold a $AVXL position is the odds of re-examination leading to approval in some form.

The ChatGPT supported views on that are already in full flow - although I don't yet see a clear picture of approval odds opinions.
icon url

williamssc

11/20/25 9:59 AM

#509091 RE: Cpap21 #509076

I see the company's request for re-exam as a positive signal. I use the mabs approval as example. Blarcamesine's a good drug and will likely be adding in December. Also looking forward to FDA's opinion.